PMID: 7018871Jul 1, 1981Paper

Treatment of Nongonococcal bacterial septic arthritis

Drug Intelligence & Clinical Pharmacy
G L Fraser

Abstract

Septic arthritis carries significant morbidity and mortality, necessitating prompt, appropriate therapy with joint fluid aspiration, intravenous antibiotics, and occasionally, surgical intervention. The initial choice of antimicrobial agent is guided by the results of synovial fluid gram stain, by identification of the pathogenesis of the primary focus, or by epidemiologic factors. Adequacy of therapy is assessed by serial synovial fluid white blood cell counts and by determining antimicrobial concentrations in the joint space. The goal of treatment is a clinically normal and sterile joint. Factors that may affect antimicrobial joint penetration include the degree of joint tissue inflammation, the degree of drug protein binding, and the chemical characteristics of the drug. Perhaps most important in determining the extent of joint penetration are factors that may affect serum antibiotic concentrations, for example, dose, route of administration, volume of distribution, but rate of elimination.

References

Mar 1, 1977·The Medical Clinics of North America·J R Ward, S G Atcheson
Nov 1, 1979·The Journal of Antimicrobial Chemotherapy·P J Wilkinson, D S Reeves
Jan 1, 1978·The Journal of Pediatrics·T R TetzlaffJ Larrondo
May 1, 1978·The Journal of Infectious Diseases·L R Levine, E McCain
Nov 1, 1978·Antimicrobial Agents and Chemotherapy·R H FitzgeraldJ A Washington
Oct 1, 1977·Antimicrobial Agents and Chemotherapy·T H Dee, F Kozin
Oct 1, 1975·Postgraduate Medicine·J R Ward
Sep 1, 1971·Clinical Pharmacology and Therapeutics·E A Baciocco, R L Iles
Aug 17, 1974·British Medical Journal·J H Newman
Oct 1, 1969·Arthritis and Rheumatism·F R Schmid, R H Parker
Jan 1, 1972·Annals of the Rheumatic Diseases·A S Russell, B M Ansell
Sep 1, 1972·Clinical Pharmacology and Therapeutics·A HowellG N Rolinson
Jul 15, 1971·The New England Journal of Medicine·A ChowR Winters
Feb 18, 1971·The New England Journal of Medicine·J D Nelson
Jan 1, 1971·Arthritis and Rheumatism·R H Parker, F R Schmid
Aug 1, 1980·Arthritis and Rheumatism·J RosenthalW D Robinson
Sep 1, 1960·Archives of Internal Medicine·R F WILLKENSJ L DECKER

❮ Previous
Next ❯

Citations

Oct 1, 1983·Acta Orthopaedica Scandinavica·C TörholmL Lidgren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

American Family Physician
Diane Lewis HorowitzMaria-Louise Barilla-LaBarca
American Journal of Therapeutics
Michael Levine, Lori B Siegel
Clinical Microbiology Reviews
Mark E Shirtliff, Jon T Mader
© 2021 Meta ULC. All rights reserved